To identify new genes that may contribute to the metastatic pathway of neop
lastic cells, we compared mRNA expression of the parental human melanoma ce
ll line 1F6 and its metastatic variant 1F6m using mRNA differential display
. We isolated a cDNA clone that was exclusively expressed in 1F6m. Northern
blot analysis on a broader panel of human melanoma cell lines with differe
nt metastatic capacity following s.c. inoculation into nude mice demonstrat
ed that the gene was expressed only in the most aggressive, highly metastat
ic cell lines, giving a band of 0.5 kb. The isolated full length cDNA clone
showed an open reading frame of 97 amino acids. To study the subcellular l
ocalization of the gene product, COS-I cells were transfected with cDNA of
the gene fused to eGFP. We found the fusion protein to be exclusively prese
nt in the nucleus.
A computer search showed strong homology with human genomic clones all loca
lized on chromosome X (Xq26.3-Xq27.1) and with several expressed sequence t
ags, all from testis. Localization of the gene on chromosome X was confirme
d by genomic PCR on a panel of human chromosome-specific rodent/human hybri
d cell lines.
Northern blotting and reverse transcription-PCR on 17 different normal huma
n tissue samples showed that the gene was only expressed in normal testis.
Reverse transcription-PCR on a great number of different human tumor cell l
ines showed expression in 25-30% of the melanoma and bladder carcinoma cell
lines. Only 2 of 29 other tumor cell lines were positive. Nested PCR analy
sis of a series of fresh human melanocytic tumors demonstrated expression i
n 7 of 10 melanomas tested. No expression was seen in benign melanocytic tu
mors. In addition to melanoma, some malignant tumors from other histologica
l types were also found to be positive.
Based on these data, we conclude that the described gene, CTp11 (cancer/tes
tis-associated protein of 11 kDa), is a novel member of the family of cance
r/testis antigens.